203 related articles for article (PubMed ID: 10526666)
21. BRCA genes--bookmaking, fortunetelling, and medical care.
Healy B
N Engl J Med; 1997 May; 336(20):1448-9. PubMed ID: 9145684
[No Abstract] [Full Text] [Related]
22. Genetic testing for cancer: a complex decision.
Harv Womens Health Watch; 2001 Feb; 8(6):2-4. PubMed ID: 11175466
[No Abstract] [Full Text] [Related]
23. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C
JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675
[TBL] [Abstract][Full Text] [Related]
24. Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.
Kiechle M; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Gerber WD; Albacht B; Fischer B; Schlegelberger B; Arnold N
Hum Mutat; 2000 Dec; 16(6):529-30. PubMed ID: 11102986
[TBL] [Abstract][Full Text] [Related]
25. Genetic tests forge ahead, despite scientific concerns.
Marshall A
Nat Biotechnol; 1996 Dec; 14(13):1642-3. PubMed ID: 9634835
[No Abstract] [Full Text] [Related]
26. Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk.
Tercyak KP; Lerman C; Peshkin BN; Hughes C; Main D; Isaacs C; Schwartz MD
Health Psychol; 2001 May; 20(3):217-22. PubMed ID: 11403219
[TBL] [Abstract][Full Text] [Related]
27. [Under what conditions should we propose a prophylactic mastectomy for a woman at risk?].
Gauthier-Villars M; Blandy C; Stoppa-Lyonnet D
Bull Cancer; 1999 Sep; 86(9):754-9. PubMed ID: 10576812
[No Abstract] [Full Text] [Related]
28. Risk of breast cancer in carriers of BRCA gene mutations.
Whittemore AS
N Engl J Med; 1997 Sep; 337(11):788-9. PubMed ID: 9289641
[No Abstract] [Full Text] [Related]
29. Hereditary breast cancer.
Hill A; McDermott E; O'Higgins N
Br J Surg; 1998 Aug; 85(8):1157. PubMed ID: 9718021
[No Abstract] [Full Text] [Related]
30. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ
Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977
[TBL] [Abstract][Full Text] [Related]
31. Choices--and uncertainties--for women with BRCA mutations.
Couzin J
Science; 2003 Oct; 302(5645):592. PubMed ID: 14576419
[No Abstract] [Full Text] [Related]
32. [Generic screening for breast cancer].
Ponti A; Giordano L
Epidemiol Prev; 1999; 23(4):369-71. PubMed ID: 10730478
[TBL] [Abstract][Full Text] [Related]
33. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
Grann VR; Jacobson JS; Whang W; Hershman D; Heitjan DF; Antman KH; Neugut AI
Cancer J Sci Am; 2000; 6(1):13-20. PubMed ID: 10696733
[TBL] [Abstract][Full Text] [Related]
34. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
35. Hereditary breast cancer.
Gronwald J; Menkiszak J; Tołoczko A; Zajaczek S; Kładny J; Kurzawski G; Krzystolik K; Podolski J; Lubiński J
Pol J Pathol; 1998; 49(2):59-66. PubMed ID: 9798408
[No Abstract] [Full Text] [Related]
36. [Pregnancy and risk of early breast cancer in patients sith BRCA1 and BRCA2 mutations].
Ost E; Illiger HJ
Strahlenther Onkol; 2000 Jul; 176(7):335-6. PubMed ID: 10963002
[No Abstract] [Full Text] [Related]
37. Hereditary breast cancer.
Hicken GJ; Francis A; Harries SA
Br J Surg; 1998 Apr; 85(4):570-1. PubMed ID: 9607548
[No Abstract] [Full Text] [Related]
38. Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
Sarantaus L; Huusko P; Eerola H; Launonen V; Vehmanen P; Rapakko K; Gillanders E; Syrjäkoski K; Kainu T; Vahteristo P; Krahe R; Pääkkönen K; Hartikainen J; Blomqvist C; Löppönen T; Holli K; Ryynänen M; Bützow R; Borg A; Wasteson Arver B; Holmberg E; Mannermaa A; Kere J; Kallioniemi OP; Winqvist R; Nevanlinna H
Eur J Hum Genet; 2000 Oct; 8(10):757-63. PubMed ID: 11039575
[TBL] [Abstract][Full Text] [Related]
39. A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families.
Vahteristo P; Eerola H; Tamminen A; Blomqvist C; Nevanlinna H
Br J Cancer; 2001 Mar; 84(5):704-8. PubMed ID: 11237395
[TBL] [Abstract][Full Text] [Related]
40. [Clinical counseling and care of women with genetic predisposition to breast and ovarian carcinoma].
Schmutzler RK; Kempe A; Kiechle M; Beckmann MW
Dtsch Med Wochenschr; 1999 May; 124(18):563-6. PubMed ID: 10356583
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]